Who are the peers of the Transgene Biotek?

Peers: The peers of Transgene Biotek are Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., Samsrita Labs, Shree Pacetronix, Adeshwar Meditex, and Family Care.
Quality Snapshot: Excellent management risk is observed at Dr Lal Pathlabs, while Good management risk is found at Syngene Intl., Poly Medicure, Indegene, Vijaya Diagnost., and Shree Pacetronix, and the rest. Average management risk is noted at Family Care, while Below Average management risk is seen at Adeshwar Meditex. Management risk does not qualify for Transgene Biotek, Samsrita Labs, and Chennai Meena. Growth is classified as Good at Family Care, Average at Poly Medicure, Indegene, and the rest, and Below Average at Syngene Intl., Dr Lal Pathlabs, Vijaya Diagnost., and Shree Pacetronix. Growth does not qualify for Transgene Biotek, Samsrita Labs, and Chennai Meena. Capital Structure is Excellent for Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., and Family Care, while Good is seen at Shree Pacetronix, and Below Average at Adeshwar Meditex.

Return Snapshot: The peer with the highest 1-year return is Poly Medicure at 24.17%, while the lowest is Shree Pacetronix at -60.83%. Transgene Biotek's 1-year return is -33.00%, which is higher than Shree Pacetronix but lower than Poly Medicure. Additionally, the six-month return is negative for Syngene Intl., Poly Medicure, Vijaya Diagnost., Shree Pacetronix, Family Care, and Chennai Meena.